ArticleFrontiers in medicine2022

Serum Metabolomics Benefits Discrimination Kidney Disease Development in Type 2 Diabetes Patients.

Xiaofeng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.